E Med Future (EMDF:BB) Receives Largest Order in Company History

E Med Future Inc. (EMDF:BB) Received $5,000,000 PO from the International Africa Aids foundation for its Needlezap device for distribution in 54 African territories.

We are pleased that The International Africa AIDS Foundation has included NeedleZap® as part of their effort to focus on eliminating the re-use of contaminated needles as a way to help curtail the spread of HIV/AIDS on the African continent

Columbus, OH (PRWEB) December 29, 2004 -- E Med Future, Inc. (OTCBB: EMDF) has received a five million dollar ($5,000,000) purchase order for NeedleZap®, a device that disintegrates used injection needles, from the International Africa AIDS Foundation, said Dane Donohue, Executive Vice President.

According to Donohue, Ray Bailey, Chairman of The International Africa AIDS Foundation, a private foundation, plans to distribute NeedleZap® units throughout the 54 African countries during the first half of 2005. The terms of the purchase order require the Foundation to prepay for all NeedleZap® units prior to shipment.

"We are pleased that The International Africa AIDS Foundation has included NeedleZap® as part of their effort to focus on eliminating the re-use of contaminated needles as a way to help curtail the spread of HIV/AIDS on the African continent," said Donohue. A recent report released by the United Nations estimates that 25.4 million people in sub-Saharan Africa are infected with HIV, an increase of 1 million from the 2003 report.

NeedleZap® is currently being used in hospitals and clinics in the African countries of Uganda and Ghana. In addition, dignitaries and Ambassadors from more than 20 African nations attended a formal introduction of NeedleZap® in Washington, D.C. last month.

For more information about E Med Future or NeedleZap®, call 877-855-1319 or visit www.needlezap.com.

Statements that describe E Med's future plans, objectives or goals are forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as E Med "expects," "anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of E Med, as appropriate, and market valuations of their stock, which could cause actual results to differ materially from those currently anticipated. Please refer to E Med's 10-K, 10-Qs and other filings with the SEC for a description of other factors that could cause actual results to differ from those anticipated.

Contact:
E Med Future, Inc.
Don Sullivan, 877-855-1319
info@needlezap.com

# # #

aids hiv medical stocks small cap stocks fda africa infectious diseases.

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl